WELCOME TO THE DISCOVERY BIOLOGY STAGE

WHAT TO EXPECT: 

AI is changing how biological insight is generated, validated, and translated into therapeutic opportunity.

The Discovery Biology Stage focuses on how leading organisations are applying AI across early-stage drug discovery - from target identification and validation to hypothesis generation and decision-making under uncertainty.

Discover how teams are integrating multimodal data, embedding AI into discovery workflows, and accelerating biological understanding across increasingly complex R&D environments.

The organisations combining biological expertise with scalable AI capabilities will shape the future of drug discovery.

DISCOVERY BIOLOGY STAGE SPEAKERS:

WHO ATTENDS:

Expect candid discussions on:

AI-driven target identification and validation

Multimodal data integration across early discovery

AI-powered hypothesis generation and biological insight

Embedding AI into discovery biology workflows

Predictive models for biological decision-making

Scaling AI across translational and preclinical research

Improving confidence and reducing uncertainty in early discovery

Connecting biological data, analytics, and experimental design

Built for the teams scaling AI across early-stage drug discovery.

Discover where AI is delivering value in discovery biology

Learn how leading organisations are applying AI across target discovery, validation, and biological analysis to accelerate decision-making and improve research efficiency.

Leave with practical implementation strategies

Understand how teams are embedding AI into discovery workflows, integrating multimodal datasets, and operationalising AI across complex biological research environments.

Improve biological insight under increasing complexity

Explore how AI is helping researchers navigate uncertainty, generate stronger hypotheses, prioritise targets more effectively, and unlock higher-quality insights across early discovery.

FAQ

The Discovery Biology Stage is designed for leaders across discovery biology, translational research, computational biology, AI, bioinformatics, and early-stage R&D within pharma, biotech, and life sciences organisations.

If you are applying AI to improve biological insight, accelerate target discovery, or scale decision-making across early research, this stage is built for you.

Discover how organisations are using AI to improve target identification, biological understanding, hypothesis generation, and decision-making across early discovery.

Sessions focus on practical implementation, multimodal data integration, workflow adoption, and the operational realities of scaling AI across discovery biology environments.

Most AI events focus on future potential.

This stage focuses on operational application - how organisations are embedding AI into discovery workflows today to improve biological insight, accelerate research, and support better decision-making under uncertainty.

Less hype. More implementation.

Both.

The Discovery Biology Stage bridges scientific strategy with operational execution — covering workflow integration, data readiness, AI deployment, organisational adoption, and the practical challenges of embedding AI into discovery environments.

Yes.

Expect a mix of talks, deployment stories, and live demonstrations from organisations already applying AI across discovery biology and early-stage drug discovery.

Sessions will focus on measurable impact, implementation lessons, workflow integration, and the practical realities of scaling AI in research environments.